Cumberland Pharmaceuticals Inc (CPIX)

2.23 -0.14 (-5.91%) USD  |  NASDAQ  |  Jan 08, 16:00
2.23 0.00 (0.00%) After-Hours: 20:00
More

Cumberland Pharmaceuticals SG&A Expense (Quarterly): 7.073M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CPIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Chimerix Inc 5.173M
Eli Lilly and Co 2.100B
NovaBay Pharmaceuticals Inc 2.65M
Palatin Technologies Inc 2.021M
iBio Inc 2.801M